Logo-ipp

Immunopathol Persa. 2019;5(1): e02. doi: 10.15171/ipp.2019.02

Original Article

Elevated levels of plasma microRNA-192 in patients with lupus nephritis

Jalal Etemadi 1 ORCID, Mohammad reza Jafari Nakhjavani 2, Roza Motavalli 3, Fariba Mahmoodpoor 1, Sima Abediazar 1 * ORCID

Cited by CrossRef: 4

1- Roointan A, Gholaminejad A, Shojaie B, Hudkins K, Gheisari Y. Candidate MicroRNA Biomarkers in Lupus Nephritis: A Meta-analysis of Profiling Studies in Kidney, Blood and Urine Samples. Mol Diagn Ther. 2023;27(2):141 [Crossref]
2- Garmaa G, Nagy R, Kói T, To U, Gergő D, Kleiner D, Csupor D, Hegyi P, Kökény G. Panel miRNAs are potential diagnostic markers for chronic kidney diseases: a systematic review and meta-analysis. BMC Nephrol. 2024;25(1) [Crossref]
3- Motavalli R, Etemadi J, Soltani-Zangbar M, Ardalan M, Kahroba H, Roshangar L, Nouri M, Aghebati-Maleki L, Khiavi F, Abediazar S, Mehdizadeh A, Hojjat-Farsangi M, Mahmoodpoor A, Kafil H, Zolfaghari M, Ahmadian Heris J, Yousefi M. Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy. Cytokine. 2021;141:155452 [Crossref]
4- Abdul‐Maksoud R, Rashad N, Elsayed W, Ali M, Kamal N, Zidan H. Circulating miR‐181a and miR‐223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis. The Journal of Gene Medicine. 2021;23(5) [Crossref]